Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ORPH - Orphazyme: Game Over Man

ORPH - Orphazyme: Game Over Man

Orphazyme A/S
  • Hopes were high for Orphazyme’s arimoclomol following FDA’s controversial decision on Alzheimer’s therapy aducanumab.
  • However, the agency has rejected arimoclomol, and the company released weak guidance for 2021.
  • Orphazyme needs to tap the equity markets relatively soon, and its market valuation is crashing, which is a really bad combination.
  • I think that the business of the company isn’t worth much in its current state, and that this one is a sell.

For further details see:

Orphazyme: Game Over, Man
Stock Information
Company Name: Orphazyme A/S
Stock Symbol: ORPH
Market: NASDAQ
Menu
ORPH ORPH Quote ORPH Short ORPH News ORPH Articles ORPH Message Board
Get ORPH Alerts

News, Short Squeeze, Breakout and More Instantly...